Mankind Pharma Ltd

BSE Code : 543904
NSE Symbol : MANKIND
ISIN : INE634S01028
Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

Trade Now

Get Quotes

2,574.30 -15.00(-0.58%)

Open Price (₹)

2,600.00

Prev. Close (₹)

2,589.30

Volume (No’s)

142,479

Market Cap (₹)

106,875.56

Low Price (₹)

2,567.10

High Price (₹)

2,624.90

Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Profit and Loss

	Mar 2025 (₹.Cr)	Mar 2024 (₹.Cr)	Mar 2023 (₹.Cr)	Mar 2022 (₹.Cr)	Mar 2021 (₹.Cr)	Mar 2020 (₹.Cr)
INCOME :
Sales Turnover	9,497.80	8,629.25	8,127.15	7,486.22	5,523.18	4,794.41
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	9,497.80	8,629.25	8,127.15	7,486.22	5,523.18	4,794.41
Other Income	554.44	374.03	162.78	203.81	154.50	93.85
Stock Adjustments	13.50	48.20	-267.89	365.27	254.25	44.51
Total Income	10,065.74	9,051.48	8,022.04	8,055.30	5,931.93	4,932.77
EXPENDITURE :
Raw Materials	2,610.39	2,618.31	2,576.87	2,886.71	2,036.42	1,617.42
Power & Fuel Cost	88.97	80.91	62.00	60.36	47.16	46.49
Employee Cost	2,131.67	1,921.09	1,701.38	1,462.76	1,167.42	991.47
Other Manufacturing Expenses	203.70	145.78	113.62	93.57	56.71	57.73
Selling & Administrative Expenses	1,770.41	1,518.78	1,539.07	1,378.52	905.53	696.80
Miscellaneous Expenses	143.09	125.69	168.47	131.08	192.07	185.06
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	6,948.23	6,410.56	6,161.40	6,013.00	4,405.31	3,594.98
Operating Profit	3,117.51	2,640.92	1,860.65	2,042.30	1,526.62	1,337.79
Interest	372.28	16.93	28.23	47.54	8.23	11.10
Gross Profit	2,745.23	2,623.99	1,832.42	1,994.76	1,518.39	1,326.69
Depreciation	378.01	335.26	269.58	123.33	78.19	61.77
Profit Before Tax	2,367.22	2,288.73	1,562.84	1,871.43	1,440.20	1,264.92
Tax	469.93	411.33	291.64	429.03	346.99	341.81
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-48.19	1.24	22.94	52.98	8.84	-35.11
Reported Net Profit	1,945.48	1,876.16	1,248.26	1,389.42	1,084.37	958.23
Extraordinary Items	254.30	105.89	29.02	62.07	30.09	18.58
Adjusted Net Profit	1,691.18	1,770.27	1,219.24	1,327.35	1,054.28	939.65
Adjustment below Net Profit	4.98	-6.66	-4.86	-0.79	-1.56	-69.15
P & L Balance brought forward	9,763.97	7,894.47	6,624.90	5,236.27	3,747.13	3,160.50
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	302.44
P & L Balance carried down	11,714.43	9,763.97	7,868.30	6,624.90	4,829.95	3,747.13
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	755.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	7.55
Earnings Per Share-Unit Curr	47.15	46.83	31.16	34.68	27.07	23.92
Earnings Per Share(Adj)-Unit Curr	47.15	46.83	31.16	34.68	27.07	23.92
Book Value-Unit Curr	354.83	242.21	194.31	163.27	118.18	91.15
Book Value(Adj)-Unit Curr	354.83	242.21	194.31	163.27	118.18	91.15